Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats.

The in vivo uptake by hepatocytes and biliary excretion of fluorescein isothiocyanate-labeled polystyrene microsphere with a particle size of 50 nm (MS-50) after intravenous administration was studied in rats. It was confirmed by using confocal laser scanning microscopy that MS-50 was partially phagocytosed by the hepatocytes and that MS-50 taken up by the hepatocytes existed exclusively inside the cells 1 h after intravenous administration. Studies on the mechanism of the uptake of MS-50 by the hepatocytes using the liver perfusion technique revealed that a process mediated by apo-E was involved. After intravenous administration of MS-50, about 4% of dose was excreted into bile in 24 h. Pharmacokinetic evaluation of the excretion rate of MS-50 into bile showed that the process followed first-order kinetics. Qualitative evaluation of the fluorescence detected in the bile after intravenous administration of MS-50 revealed that the particles were certainly excreted into bile in an intact form. From these results, it was suggested that intravenously administered MS-50 would be partially phagocytosed by hepatocytes through a process mediated by apo-E and that MS-50 ingested by hepatocytes would be partially excreted into the bile.

[1]  R. Mikkelsen,et al.  Studies on fenestral contraction in rat liver endothelial cells in culture. , 1996, The American journal of pathology.

[2]  M. Hashida,et al.  Mechanisms of hepatic disposition of polystyrene microspheres in rats: effects of serum depend on the sizes of microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[3]  M. Hashida,et al.  Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Dexi Liu,et al.  Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. , 1995, Biochimica et biophysica acta.

[5]  H. Sasaki,et al.  Lipid nano-sphere(LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IV. , 1994 .

[6]  M. Hashida,et al.  Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands. , 1999, Journal of drug targeting.

[7]  J. K. Kruijt,et al.  Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B , 1995, Nature Medicine.

[8]  K. Okita,et al.  Recent clinical studies on lipo-PGE1 and lipo-PGI2: PGE1 and PGI2 incorporated in lipid microspheres, for targeted delivery , 1994 .

[9]  K. Funato,et al.  The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ. , 1994, Journal of drug targeting.

[10]  M. Hashida,et al.  Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). , 1997, Biochemical pharmacology.

[11]  L. Huang,et al.  Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. , 1992, Biochimica et biophysica acta.

[12]  D. Hochstrasser,et al.  Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.

[13]  D. Herbert,et al.  Evidence that hepatocytes can phagocytize exogenous substances , 1992, The Anatomical record.

[14]  A. Cooper Hepatic uptake of chylomicron remnants. , 1997, Journal of lipid research.

[15]  V. Kolb‐Bachofen Uptake of toxic silica particles by isolated rat liver macrophages (Kupffer cells) is receptor mediated and can be blocked by competition. , 1992, The Journal of clinical investigation.